Search

Displaying results 71 - 78 of 78 in total
  1. Indication

    Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)

    go.drugbank.com/conditions/DBCOND0138147
    Drugs: Cetuximab · Docetaxel · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab
  2. Indication

    Metastatic Urothelial Carcinoma (UC)

    go.drugbank.com/conditions/DBCOND0073677
    Drugs: Durvalumab · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab · Pemetrexed
  3. Indication

    Metastatic Cervical Cancer

    go.drugbank.com/conditions/DBCOND0036674
    Drugs: Bevacizumab · Cemiplimab · Irinotecan · Pembrolizumab · Pemetrexed · Tisotumab vedotin +1 more
  4. Indication

    Hepatocellular Carcinoma

    go.drugbank.com/conditions/DBCOND0030090
    Drugs: Cabozantinib · Capecitabine · Hyaluronidase (human recombinant) · Ipilimumab · Nivolumab · Pembrolizumab +2 more
  5. Indication

    Advanced Renal Cell Carcinoma

    go.drugbank.com/conditions/DBCOND0032596
    Drugs: Avelumab · Axitinib · Belzutifan · Cabozantinib · Hyaluronidase (human recombinant) · Lenvatinib +6 more
  6. Indication

    Unresectable Melanoma

    go.drugbank.com/conditions/DBCOND0047213
    Drugs: Atezolizumab · Binimetinib · Cobimetinib · Dabrafenib · Encorafenib · Hyaluronidase (human recombinant) +7 more
  7. Indication

    Metastatic Melanoma

    go.drugbank.com/conditions/DBCOND0030058
    Drugs: Aldesleukin · Atezolizumab · Binimetinib · Cobimetinib · Dabrafenib · Dacarbazine +13 more
  8. Indication

    Metastatic Non-Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0043377
    Drugs: Adagrasib · Afatinib · Amivantamab · Atezolizumab · Binimetinib · Brigatinib +32 more